KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Other Non Operating Income: 2018-2025

Historic Other Non Operating Income for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $420,000.

  • Twist Bioscience's Other Non Operating Income rose 118.04% to $420,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$736,000, marking a year-over-year increase of 72.53%. This contributed to the annual value of -$903,000 for FY2025, which is 66.29% up from last year.
  • As of Q3 2025, Twist Bioscience's Other Non Operating Income stood at $420,000, which was up 150.24% from -$836,000 recorded in Q2 2025.
  • Twist Bioscience's Other Non Operating Income's 5-year high stood at $420,000 during Q3 2025, with a 5-year trough of -$2.3 million in Q3 2024.
  • Over the past 3 years, Twist Bioscience's median Other Non Operating Income value was -$199,000 (recorded in 2024), while the average stood at -$357,182.
  • Over the last 5 years, Twist Bioscience's Other Non Operating Income had its largest YoY gain of 366.67% in 2021, and its largest YoY loss of 1,768.42% in 2021.
  • Twist Bioscience's Other Non Operating Income (Quarterly) stood at -$156,000 in 2021, then dropped by 0.64% to -$157,000 in 2022, then soared by 80.25% to -$31,000 in 2023, then crashed by 122.58% to -$69,000 in 2024, then spiked by 118.04% to $420,000 in 2025.
  • Its last three reported values are $420,000 in Q3 2025, -$836,000 for Q2 2025, and -$251,000 during Q1 2025.